• Elephas Biosciences appointed immunotherapy researcher Francesco Marincola to its Scientific Advisory Board.
• Marincola is chief scientific officer, global head of research at Translational and Advanced Medicine.
• He previously held leadership roles at Sonata Therapeutics, Kite Pharma, Refuge Biotechnologies, AbbVie, Sidra Medical and Research Centre.
• Appointment comes as Elephas advances commercialization, expands clinical collaborations, accelerates discovery using its elive platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elephas Biosciences Corp. published the original content used to generate this news brief on June 03, 2026, and is solely responsible for the information contained therein.